Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | CA2 | P00918 | 9/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12208185 | 0.93 | CA2 (0.47) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL13013753 | 0.91 | LMNA (0.50) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL29273648 | 0.91 | LMNA (0.50) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL28541213 | 0.91 | LMNA (0.50) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL28752342 | 0.91 | CA2 (0.47) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL2078015 | 0.86 | TDP1 (0.42) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL2077448 | 0.86 | TDP1 (0.42) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL20225964 | 0.86 | TDP1 (0.42) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| Acetamide SCHEMBL28866560 | 0.85 | CA2 (0.44) | ALDH1A1CA2CYP3A4TSHRTDP1 | |
| SCHEMBL17676325 | 0.84 | LMNA (0.52) | CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12222653-B2 | Method for forming semiconductor structure | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2025-02-11 | — | — | US | disclosed |
| US-20210286269-A1 | METHOD FOR FORMING SEMICONDUCTOR STRUCTURE | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2021-09-16 | — | — | US | disclosed |
| US-20210286269-A1 | METHOD FOR FORMING SEMICONDUCTOR STRUCTURE | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2021-09-16 | — | — | US | disclosed |
| US-11009796-B2 | Method for forming semiconductor structure | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2021-05-18 | — | — | US | disclosed |
| US-11009796-B2 | Method for forming semiconductor structure | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2021-05-18 | — | — | US | disclosed |
| US-10990013-B2 | Method for forming semiconductor structure | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2021-04-27 | — | — | US | disclosed |
| US-10990013-B2 | Method for forming semiconductor structure | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2021-04-27 | — | — | US | disclosed |
| US-10838304-B2 | Priming material for organometallic resist | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2020-11-17 | — | — | US | disclosed |
| CN-110828302-A | Film forming method | 台湾积体电路制造股份有限公司 | 2020-02-21 | — | — | CN | disclosed |
| US-20200050109-A1 | Priming Material for Organometallic Resist | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2020-02-13 | — | — | US | disclosed |
| US-20100267781-A1 | NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2010-10-21 | — | — | US | disclosed |
| US-20100267781-A1 | NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2010-10-21 | — | — | US | disclosed |
| WO-2010026989-A1 | ORTHO-SUBSTITUTED HALOALKYLSULFONANILIDE DERIVATIVE AND HERBICIDE | 日産化学工業株式会社 (JP) | 2010-03-11 | — | — | WO | disclosed |
| US-20090105319-A1 | NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2009-04-23 | — | — | US | disclosed |
| US-20090105319-A1 | NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2009-04-23 | — | — | US | disclosed |
| WO-2007025307-A2 | INHIBITORS OF SERINE PROTEASES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-03-01 | — | — | WO | disclosed |
| US-6825373-B2 | REACTING AN AMINOPYRROL DERIVATIVE WITH AND ISOTHIOCYANATOFORMIC ACID ESTER DERIVATIVE TO FORM AN ADDUCT,CYCLIZING THE ADDUCT TO FORM PYRROLOTRIAZIN-4-ONE DERIVATIVE | FUJI PHOTO FILM CO., LTD. (JP) | 2004-11-30 | — | — | US | disclosed |
| US-6600041-B2 | Cyclization of an aminopyrrole compound | FUJI PHOTO FILM CO., LTD. (JP) | 2003-07-29 | — | — | US | disclosed |
| US-20020128479-A1 | Method of preparing pyrrolotriazin-4-one compound and method of preparing isothiocyanatoformic acid ester derivative that is a reactant used for preparing pyrrolotriazin-4-one compound | FUJI PHOTO FILM CO., LTD. | 2002-09-12 | — | — | US | disclosed |
| US-20020010330-A1 | Method of preparing pyrrolotriazin-4-one compound and method of preparing isothiocyanatoformic acid ester derivative that is a reactant used for preparing pyrrolotriazin-4-one compound | FUJI PHOTO FILM CO., LTD. | 2002-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010330-A1 | Method of preparing pyrrolotriazin-4-one compound and method of preparing isothiocyanatoformic acid ester derivative that is a reactant used for preparing pyrrolotriazin-4-one compound | PPOX, QPCT, DDT | ALDH1A1 461/4885CA2 2982/4885CYP3A4 34/4885 |
| US-20100267781-A1 | NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS | HAX1, BAX, APOL1 | ALDH1A1 4349/4885CA2 2778/4885CYP3A4 2547/4885 |
| US-20090105319-A1 | NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS | HAX1, BAX, APOL1 | ALDH1A1 4254/4885CA2 2843/4885CYP3A4 2395/4885 |
| US-20020128479-A1 | Method of preparing pyrrolotriazin-4-one compound and method of preparing isothiocyanatoformic acid ester derivative that is a reactant used for preparing pyrrolotriazin-4-one compound | PPOX, QPCT, DDT | ALDH1A1 461/4885CA2 2982/4885CYP3A4 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.